The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 17, 2024
Filed:
Oct. 12, 2021
Applicant:
Novartis Ag, Basel, CH;
Inventors:
Simone Bonazzi, Cambridge, MA (US);
Michael Connolly, Salem, MA (US);
David Jonathan Glass, Cortland Manor, NY (US);
Manuel Mihalic, Grenzach-Wyhlen, DE;
Andrew William Patterson, Somerville, MA (US);
Silvio Roggo, Muttenz, CH;
Tea Shavlakadze, Hawthorne, NY (US);
Assignee:
NOVARTIS AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/18 (2006.01); A61P 1/16 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61P 13/12 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 25/02 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/10 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07F 9/6561 (2006.01);
U.S. Cl.
CPC ...
C07D 498/18 (2013.01); A61P 1/16 (2018.01); A61P 3/04 (2018.01); A61P 3/10 (2018.01); A61P 9/10 (2018.01); A61P 9/12 (2018.01); A61P 11/00 (2018.01); A61P 13/12 (2018.01); A61P 19/00 (2018.01); A61P 19/02 (2018.01); A61P 19/10 (2018.01); A61P 25/02 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61P 29/00 (2018.01); A61P 31/10 (2018.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07F 9/6561 (2013.01);
Abstract
The disclosure relates to compounds of formula (I) and pharmaceutically acceptable salts, and compositions thereof, wherein the substituents are as defined herein. Also provided are methods of making compounds of formula (I), and methods involving the compounds or compositions for treating disorders and diseases described herein.